TrialArab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology2022

Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals.

Mohammed A Medhat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.